In a global dental materials market long dominated by Western and Japanese brands, a Beijing-based enterprise is redefining expectations. Beijing AT&M BIOMATERIALS Co., Ltd., under the leadership of founder and chairman Qi Wang, is establishing its position in advanced dental restorative materials—not by following, but by innovating.
Qi Wang, whose background spans finance, management, and cultural arts, brings a distinctive leadership perspective to a field traditionally governed by scientific orthodoxy. Her multidisciplinary path has enabled her to see connections where others see boundaries. “Every industry has its own logic, but innovation often happens at the intersections,” she says. It is this mindset that has guided Beijing AT&M BIOMATERIALS Co., Ltd.’s evolution from a specialized materials manufacturer to a globally oriented medical innovator.
Founded with the goal of contributing to human oral health, Beijing AT&M BIOMATERIALS has prioritized independent R&D and technological self-reliance from the beginning. The company operates several dedicated laboratories, including the Oral Polymer Materials Engineering Laboratory and the Digital Dentistry Laboratory, and collaborates with leading institutions such as Peking University School of Stomatology and West China Medical Center of Sichuan University.
Wang’s strategic emphasis on deeply integrated R&D has led to a suite of proprietary technologies, including advanced bonding agents, etching systems, and root surface protection materials. The company’s flagship light-cured nanocomposite resin became the first dental resin in China to receive a Class III registration certificate.
This innovation- and quality-oriented approach has significantly enhanced the company’s credibility. Its product line complies with ISO 9001 and ISO 13485 standards, holds both CE and CFDA certifications, and has maintained a zero patient complaint record since launch. Materials from AT&M are now widely endorsed by clinicians in over 100 countries for their reliability, ease of use, and cost-effectiveness compared to legacy brands.
At a time when global healthcare markets place growing emphasis on performance standards and supply chain security, Beijing AT&M BIOMATERIALS is positioning itself as a high-quality, high-compliance alternative to traditional brands. As Wang puts it: “We don’t aim to be cheaper. We aim to be better.”
Wang has also led major infrastructure investments. In 2024, the company relocated to a new production base equipped for next-generation automation and full GMP compliance. Backed by more than RMB 20 million in capital investment, the facility will support AT&M’s efforts to scale production and modernize manufacturing systems across its entire product portfolio.
Beyond manufacturing, Beijing AT&M BIOMATERIALS has developed supply chain and quality management systems that reflect a level of operational maturity often seen in much larger firms. The company has implemented a closed-loop Quality Management System (QMS) and Product Lifecycle Management (PLM) platform that tracks every stage—from lab design to post-market surveillance. It conducts regular supplier audits and has developed standardized risk management protocols to ensure traceability, regulatory compliance, and continuous improvement.
As part of its global roadmap, the company is establishing regional offices in Japan and the United States. Wang is also leading the rollout of next-generation products, including a “one-shade” color-adaptive resin and printable composite materials for permanent crowns—designed to meet growing demand for digital dentistry and chairside customization.
While many manufacturers continue to compete on cost, Beijing AT&M BIOMATERIALS represents something different: a vertically integrated, research-driven company that prioritizes quality and scales with strategic intent. Its trajectory reflects a broader shift underway in China’s industrial landscape—from volume-driven manufacturing to value-added innovation.
And at the helm of it all is Qi Wang, whose cross-sector insight and pragmatic leadership have guided the company’s transformation from a domestic supplier into a globally competitive force. “We are committed to deepening our presence in the field and taking a long-term view,” she says. “With the mindset of ‘ten years to sharpen one sword,’ we are upgrading our entire product portfolio, serving the public, and stepping onto the global stage.”
